Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ResHypOT: SNB vs DBB in Resistant Hypertension
NCT02832973Phase 4Completed
- Sponsor
- Faculdade de Medicina de São José do Rio Preto
- Start
- Sep 2015
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of spironolactone, furosemide, amiloride in resistant hypertension (RH), sponsored by Faculdade de Medicina de São José do Rio Preto. Started Sep 2015; status: completed.
02
Drugs
spironolactonefurosemideamiloride
03
Conditions
resistant hypertension (RH)
Beyond the preview
Go deeper on NCT02832973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02832973.